View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Trastuzumab Deruxtecan 6.4, adenocarcinoma esophagogastric junction and stomach
Protocol-ID: 2253 V1.0 (Mini), TRASDE6.4, AEG/Gastric CaIndication(s)
- Gastric Cancer (HER2+); ICD-10 C16.-, C16.0
- Esophageal Cancer (Adenocarcinoma of the esophagogastric junction (AEG), HER2+); ICD-10 C15.-
Links
- ENHERTU (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 03.02.2023